Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

He works in mysterious ways.

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

Patients with severe hypertriglyceridemia have an increased risk of acute pancreatitis. The efficacy and safety of olezarsen, an antisense oligonucleotide targeting apolipoprotein C-III messenger RNA, ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that detailed data from the landmark pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG) ...

Good morning, and welcome to Ionis Conference Call to discuss Olezarsen CORE and CORE2 top line data. As a reminder, this call is being recorded. At this time, I would like to turn the call over to ...

Andy is a seasoned technology journalist with more than 15 years experience in the mobile industry, writing for Digital Trends, Wired, and more. During that time he has reviewed hundreds of ...

What if your development process could feel less like a juggling act and more like a well-orchestrated symphony? For solo developers, the challenge of managing everything—from brainstorming and coding ...

On a mission to expand its recently approved Tryngolza beyond the rare genetic disorder familial chylomicronemia syndrome (FCS), Ionis recently tested its medicine in patients with moderate ...

At its latest product launch event, Meizu unveiled the next major evolution of its operating system: Flyme AIOS 2. Debuting on the newly announced Meizu Note 16 and Note 16 Pro, the update is far more ...